Loading...
A case of checkpoint inhibitor-induced celiac disease
BACKGROUND: Immune checkpoint inhibitors (ICIs) have now become standard of care treatment for many malignancies. ICIs are associated with unique immune mediated adverse events (irAEs) due to dysregulation of immune activation. As treatment with ICIs is becoming more common, rare irAEs are also bein...
Na minha lista:
| Udgivet i: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683380/ https://ncbi.nlm.nih.gov/pubmed/31383006 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0694-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|